Study examines opioid agonist therapy use in Medicare patients

July 20, 2016, The JAMA Network Journals

Few Medicare enrollees appear to be receiving buprenorphine-naloxone, the only opioid agonist therapy for opioid addiction available through Medicare Part D prescription drug coverage, according to a study published online by JAMA Psychiatry.

Opioid overdose rates reached record highs in 2014. The Medicare population has among the highest and fastest growing prevalence of opioid use disorder, with more than 6 of every 1,000 (an estimated 300,000 of 55 million) diagnosed. Opioid agonist therapy (OAT), including buprenorphine-naloxone and methadone, is the most effective drug therapy for opioid addiction. Medicare Part D does not pay for methadone maintenance therapy so buprenorphine-naloxone is the only Medicare covered option for patients addicted to opioids. Part D covers 68 percent of the roughly 55 million people on Medicare.

Anna Lembke, M.D., and Jonathan H. Chen, M.D., Ph.D., of the Stanford University School of Medicine, California, examined 2013 Medicare Part D claims data from individual prescribers.

The authors identified 6,707 prescribers with 486,099 claims for buprenorphine-naloxone, which were written for about 81,000 patients, according to the results.

The data suggests that:

  • For every 40 family practice physicians who prescribed an , only one family practice physician prescribed buprenorphine-naloxone.
  • Pain physicians averaged a negligible number of buprenorphine-naloxone prescriptions per prescriber (mostly less than five) while averaging thousands of opioid prescriptions.
  • Prescribers with a primary specialty in addiction medicine prescribed the most buprenorphine-naloxone with nearly 99 claims per year per prescriber.

Authors note the data do not necessarily completely reflect clinician practices or patient factors.

"Approximately 81,000 Medicare enrollees are receiving buprenorphine-naloxone therapy (the only OAT available through Medicare part D) despite more than 300,000 Medicare patients estimated to be struggling with an opioid use disorder and 211,200 per year requiring hospitalization for opioid overuse. We believe this reflects a significant treatment gap, although we are limited in providing precise estimates; not all patients with an opioid use disorder warrant OAT but, on the other hand, disorders are systematically underdiagnosed and increasing in prevalence," the study concludes.

Explore further: Expand prescribing of buprenorphine for opioid abuse? Experts weigh pros and cons

More information: JAMA Psychiatry. Published online July 20, 2016. DOI: 10.1001/jamapsychiatry.2016.1390

Related Stories

Expand prescribing of buprenorphine for opioid abuse? Experts weigh pros and cons

May 2, 2016
Buprenorphine is a critical part of treatment for the growing epidemic of opioid abuse—but also carries the potential for misuse and diversion. The debate over whether 'to expand or not to expand' prescribing of buprenorphine ...

Despite opioid concerns, seniors often exit the hospital with prescription, study says

July 19, 2016
It's a common scenario: Someone checks into a hospital for surgery or an illness and leaves with a prescription for an opioid painkiller, opening the door to long-term use and dependence. A recent study examined this pattern ...

Buprenorphine implants may be effective relapse prevention tool for adults with opioid dependence

July 19, 2016
While buprenorphine has long been used to treat adults with opioid dependence, its efficacy can be hindered by lack of adherence to daily, sublingual (beneath the tongue) doses of the medication. New research led by the Icahn ...

For prescription drug addiction treatment, buprenorphine maintenance trumps detoxification

October 20, 2014
For treating patients with prescription opioid dependence in primary care, buprenorphine maintenance therapy is superior to detoxification, according to a new study by Yale School of Medicine researchers published in the ...

Many addicts going without meds that curb opioid abuse

June 3, 2016
(HealthDay)—The United States is in the grip of an epidemic of opioid abuse. However, new research suggests that drugs that help addicts kick their habit after hospitalization are too seldom used.

Nearly 1 in 3 on Medicare got commonly abused opioids

June 22, 2016
Nearly 12 million Medicare beneficiaries received at least one prescription for an opioid painkiller last year at a cost of $4.1 billion, according to a federal report that shows how common the addictive drugs are in many ...

Recommended for you

Researchers discover abundant source for neuronal cells

December 13, 2018
USC researchers seeking a way to study genetic activity associated with psychiatric disorders have discovered an abundant source of human cells—the nose.

New genetic clues to early-onset form of dementia

December 13, 2018
Unlike the more common Alzheimer's disease, frontotemporal dementia tends to afflict young people. It accounts for an estimated 20 percent of all cases of early-onset dementia. Patients with the illness typically begin to ...

Video game players frequently exposed to graphic content may see world differently

December 13, 2018
People who frequently play violent video games are more immune to disturbing images than non-players, a UNSW-led study into the phenomenon of emotion-induced blindness has shown.

How teens deal with stress may affect their blood pressure, immune system

December 13, 2018
Most teens get stressed out by their families from time to time, but whether they bottle those emotions up or put a positive spin on things may affect certain processes in the body, including blood pressure and how immune ...

How bullying affects the brain

December 12, 2018
New research from King's College London identifies a possible mechanism that shows how bullying may influence the structure of the adolescent brain, suggesting the effects of constantly being bullied are more than just psychological.

Increased motor activity linked to improved mood

December 12, 2018
Increasing one's level of physical activity may be an effective way to boost one's mood, according to a new study from a team including scientists at Johns Hopkins Bloomberg School of Public Health in collaboration with the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.